Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting

The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase cons...

Full description

Saved in:
Bibliographic Details
Published inEnfermedades infecciosas y microbiología clínica Vol. 24; no. 9; p. 568
Main Authors Saiz de la Hoya-Zamácola, Pablo, Marco-Mouriño, Andrés, Clemente-Ricote, Gerardo, Portilla-Sogorb, Joaquín, Boix-Martínez, Vicente, Núñez-Martínez, Oscar, Reus-Bañuls, Sergio, Teixidó i Pérez, Nuria
Format Journal Article
LanguageSpanish
Published Spain 01.11.2006
Subjects
Anti-HIV Agents - administration & dosage
Anti-HIV Agents - adverse effects
Anti-HIV Agents - therapeutic use
Antiviral Agents - administration & dosage
Antiviral Agents - adverse effects
Antiviral Agents - therapeutic use
Biopsy
Comorbidity
Disease Progression
Drug Therapy, Combination
Hepatitis C, Chronic - diagnosis
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - epidemiology
Hepatitis C, Chronic - pathology
HIV Infections - drug therapy
HIV Infections - epidemiology
Humans
Interferon-alpha - administration & dosage
Interferon-alpha - adverse effects
Interferon-alpha - therapeutic use
Liver - pathology
Liver - virology
Liver Function Tests
Patient Compliance
Polyethylene Glycols - administration & dosage
Polyethylene Glycols - adverse effects
Polyethylene Glycols - therapeutic use
Practice Guidelines as Topic
Prevalence
Prisoners - statistics & numerical data
Prisons
Randomized Controlled Trials as Topic - statistics & numerical data
Recombinant Proteins
Ribavirin - administration & dosage
Ribavirin - therapeutic use
Spain - epidemiology
Substance Abuse, Intravenous - epidemiology
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase considerably in the coming years. A group of Spanish experts with experience in patients who are inmates has been invited to establish a series of recommendations for the diagnosis and treatment of chronic hepatitis C infection in Spanish prisons.
ISSN:0213-005X